Visium Technologies: Lucky reports 9.43% stake
The extended cure deadline depends on formation of the intended special committee and cannot be later than March 1, 2027.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Visium Technologies, Inc. (VISM) reporting person Mark B. Lucky reported beneficial ownership of 119,746,869 shares, or 9.43% of the class. That amount includes 84,001 shares issuable upon conversion of Series D and Series AA preferred stock and 525,285 shares held by four trusts for which Lucky is trustee and a beneficiary.
As sole director, Lucky intends to set the board at three, elect two directors independent of him, the former CEO and principal shareholders, and establish a special committee; no directors have been elected. He delivered an October 26, 2026 notice stating that Good Reason exists under his employment agreement. The cure period was extended to the later of November 25, 2026 and 30 days after the committee is constituted, but no later than March 1, 2027. If Visium does not cure, his resignation would take effect the following day; he has not resigned. He proposed mutual separation terms to Visium, PT Smart Green Technologies and Adler Capital Limited; no agreement has been reached.
Key Figures
Key Terms
beneficially owned financial
dispositive power technical
Good Reason technical
cure period technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Has Mark B. Lucky resigned from VISM?
AI-generated analysis. How Rhea-AI works. Not financial advice.